Devimistat

DB12109InvestigationalSmall molecule

Devimistat (CPI-613) has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Advanced Cancer, and Pancreatic Cancer, among others.

Chemical structure of Devimistat
Formula / weight
C22H28O2S2 · 388.58 g/mol (avg)
Code names
CPI-613

Resolves to

Compound
UNIIE76113IR49CAS95809-78-2ChEMBLCHEMBL3186849PubChem24770514
Structure
InChIKeyZYRLHJIMTROTBO-UHFFFAOYSA-NSMILESOC(=O)CCCCC(CCSCC1=CC=CC=C1)SCC1=CC=CC=C1
Targets
Q02218OGDH

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
34Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Devimistat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In